CO6331298A2 - Vacunas contra coccidiosis - Google Patents

Vacunas contra coccidiosis

Info

Publication number
CO6331298A2
CO6331298A2 CO10146271A CO10146271A CO6331298A2 CO 6331298 A2 CO6331298 A2 CO 6331298A2 CO 10146271 A CO10146271 A CO 10146271A CO 10146271 A CO10146271 A CO 10146271A CO 6331298 A2 CO6331298 A2 CO 6331298A2
Authority
CO
Colombia
Prior art keywords
against coccidiosis
vaccines against
vaccine
coccidiosis
producing
Prior art date
Application number
CO10146271A
Other languages
English (en)
Inventor
Marcelo Lang
Charles Broussard
Joan Schrader
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of CO6331298A2 publication Critical patent/CO6331298A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/012—Coccidia antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La presente invención describe una vacuna que proporciona la protección contra la coccidiosis, y métodos para producir y usar la vacuna sola, o en combinación con otros agentes protectores.
CO10146271A 2008-05-29 2010-11-22 Vacunas contra coccidiosis CO6331298A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5700308P 2008-05-29 2008-05-29

Publications (1)

Publication Number Publication Date
CO6331298A2 true CO6331298A2 (es) 2011-10-20

Family

ID=41254633

Family Applications (1)

Application Number Title Priority Date Filing Date
CO10146271A CO6331298A2 (es) 2008-05-29 2010-11-22 Vacunas contra coccidiosis

Country Status (14)

Country Link
US (1) US9050281B2 (es)
EP (1) EP2296698A1 (es)
JP (1) JP2011521955A (es)
CN (1) CN102046197A (es)
AR (1) AR071917A1 (es)
BR (1) BRPI0912263A2 (es)
CA (1) CA2725361C (es)
CO (1) CO6331298A2 (es)
IL (1) IL208660A0 (es)
MX (1) MX2010012869A (es)
PE (1) PE20100145A1 (es)
RU (1) RU2525587C2 (es)
TW (1) TW201010717A (es)
WO (1) WO2009148895A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070077256A1 (en) 1999-11-19 2007-04-05 Los Angeles Biomedical Research Institute Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents
US8252292B2 (en) 2008-11-13 2012-08-28 Intervet International B.V. Eimeria vaccine for turkeys
US8858959B2 (en) 2011-07-15 2014-10-14 The United States Of America, As Represented By The Secretary Of Agriculture Gel vaccine delivery system for treating poultry
CN103998056B (zh) 2011-07-22 2017-09-12 诺瓦蒂格姆疗法有限公司 用于接种抗金黄色葡萄球菌疫苗的方法和组合物
EA030005B1 (ru) 2013-03-15 2018-06-29 Лос-Анджелес Биомедикал Ресерч Институт Эт Харбор-Укла Медикал Центер Композиции и способы лечения грибковых и бактериальных патогенов
CN103251938B (zh) * 2013-04-15 2015-07-15 内蒙古神元生物工程股份有限公司 鸡艾美耳球虫弱毒疫苗产业化生产工艺
MX2018005983A (es) * 2015-11-13 2019-04-22 Applied Lifesciences And Systems Llc Sistema automatico y metodo para suministrar una sustancia a un animal.
CN107019799A (zh) * 2016-01-30 2017-08-08 天津赫莱恩特生物科技有限公司 一种鸡球虫病四价弱毒活疫苗组合物在生产中的应用
CN107019704A (zh) * 2016-01-31 2017-08-08 天津赫莱恩特生物科技有限公司 提高鸡柔嫩艾美尔球虫疫苗免疫效果组合物的应用
CN107019111B (zh) * 2016-01-31 2020-11-20 天津赫莱恩特生物科技有限公司 提高巨型艾美尔球虫卵囊产量的组合物及其制备方法
JP2019507759A (ja) 2016-03-09 2019-03-22 ロサンゼルス バイオメディカル リサーチ インスティテュート アット ハーバー− ユーシーエルエー メディカル センター 外陰部膣カンジダ症の予防及び治療で使用するための方法及びキット
US20180208885A1 (en) 2017-01-24 2018-07-26 Mary Ann Pfannenstiel Antibiotic-free compositions for the prevention or control of coccidiosis
CN107670032A (zh) * 2017-10-27 2018-02-09 贵州福斯特生物科技有限公司 家禽油乳剂灭活疫苗佐剂及其相应疫苗的制备方法
CN108060085A (zh) * 2017-12-31 2018-05-22 天津赫莱恩特生物科技有限公司 一种提高毒害艾美尔球虫卵囊纯化成功率的方法
CA3104875A1 (en) * 2018-07-10 2020-01-16 Applied Lifesciences And Systems Poultry, Inc. Systems and methods of preparing and delivering gels
CN109646674B (zh) * 2019-01-25 2022-08-09 中国农业大学 一种球虫病活疫苗及其应用
WO2023170057A1 (en) 2022-03-08 2023-09-14 Hipra Scientific, S.L.U. In ovo vaccine compositions against coccidiosis

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5649323A (en) * 1979-09-29 1981-05-02 Nisshin Flour Milling Co Ltd Coccidiostat
JPS5780325A (en) 1980-09-05 1982-05-19 Nat Res Dev Coccidial disease vaccine
GB8326633D0 (en) 1983-08-04 1983-11-09 Unilever Plc Compositions
DE3785404T2 (de) * 1986-08-18 1993-07-29 British Tech Group Impfstoffe.
US4935007A (en) * 1986-08-28 1990-06-19 Eli Lilly And Company Anticoccidial method
KR960003379B1 (ko) 1986-08-28 1996-03-09 일라이 릴리 앤드 캄파니 개선된 콕시듐증 예방법
GB8711256D0 (en) * 1987-05-13 1987-06-17 Unilever Plc Protection
ZA954785B (en) 1994-06-16 1996-02-08 Yamanouchi Pharma Co Ltd Crude drug-containing feed
ATE200029T1 (de) 1995-06-07 2001-04-15 Pfizer In ovo impfung gegen coccidiose
SK282436B6 (sk) 1995-06-07 2002-02-05 Pfizer Inc. Živé sporocysty alebo oocysty Eimeria alebo ich zmesi na výrobu očkovacej látky
CA2213385A1 (en) 1997-08-20 1999-02-20 Eng-Hong Lee Method of protecting against coccidiosis infections in poultry
CA2214233A1 (en) * 1997-08-29 1999-02-28 Eng-Hong Lee Method for assessing viability of live microbial therapeutic agents
AUPP268398A0 (en) * 1998-03-30 1998-04-23 Eimeria Pty Limited Vaccination modalitites
DE19828322A1 (de) 1998-06-25 1999-12-30 Hoechst Roussel Vet Gmbh Coccidienvakzine, Verfahren zu ihrer Herstellung und ihre Verwendung
US7247309B2 (en) * 1999-12-21 2007-07-24 Intervet International B.V. Coccidiosis vaccines
AUPQ622900A0 (en) 2000-03-15 2000-04-06 University Of Melbourne, The Pcr-based identification of eimeria species and strains
US6432646B1 (en) * 2000-03-16 2002-08-13 The University Of Melbourne PCR-based identification of Eimeria species and strains
AU2002225894A1 (en) * 2000-11-08 2002-05-21 Novus International Inc Methods and compositions for the control of coccidiosis
US6969602B1 (en) * 2001-04-20 2005-11-29 The United States Of America As Represented By The Secretary Of The Agriculture Production of an immunovariant strain of Eimeria maxima contributes to strain cross-protection with other Eimeria maximas
ATE484573T1 (de) * 2001-08-30 2010-10-15 Embrex Inc Verbesserte verfahren zur herstellung von oozysten
TWI348376B (en) * 2002-02-26 2011-09-11 Wyeth Corp Selection of poultry eimeria strains through extra-intestinal sporozites
ATE526033T1 (de) * 2002-05-21 2011-10-15 Schering Plough Ltd Verfahren für die kultur von sporozoea sp. in vitro und ihre anwendungen
BR0313994A (pt) 2002-09-20 2005-07-19 Akzo Nobel Nv Parasita vivo atenuado, vacina para combater infecção parasìtica, uso de um parasita vivo atenuado, método para a produção de uma vacina, e, fragmento de dna
WO2004052393A1 (en) * 2002-12-09 2004-06-24 University Of Georgia Research Foundation, Inc. Coccidial vaccine and methods of making and using same
US7354593B2 (en) 2002-12-09 2008-04-08 Merial Limited Coccidial vaccine and methods of making and using same
WO2005089262A2 (en) 2004-03-12 2005-09-29 University Of Georgia Research Foundation, Inc. Novel peanut skin extract as a vaccine adjuvant
SI1877085T1 (sl) * 2005-04-15 2013-05-31 Merial Ltd. Cepivo proti kokcidiozi in postopki njegove izdelava in uporabe
US20080131463A1 (en) * 2006-11-30 2008-06-05 Perdue Holdings, Inc. Vaccination method for controlling coccidiosis in fowl
US8252292B2 (en) * 2008-11-13 2012-08-28 Intervet International B.V. Eimeria vaccine for turkeys

Also Published As

Publication number Publication date
US9050281B2 (en) 2015-06-09
BRPI0912263A2 (pt) 2015-10-20
RU2010153992A (ru) 2012-07-10
CN102046197A (zh) 2011-05-04
EP2296698A1 (en) 2011-03-23
JP2011521955A (ja) 2011-07-28
RU2525587C2 (ru) 2014-08-20
WO2009148895A1 (en) 2009-12-10
MX2010012869A (es) 2010-12-14
AR071917A1 (es) 2010-07-21
PE20100145A1 (es) 2010-03-05
CA2725361C (en) 2017-05-16
IL208660A0 (en) 2010-12-30
TW201010717A (en) 2010-03-16
CA2725361A1 (en) 2009-12-10
US20100015182A1 (en) 2010-01-21

Similar Documents

Publication Publication Date Title
CO6331298A2 (es) Vacunas contra coccidiosis
BRPI0815008B8 (pt) vacinas multiméricas com múltiplos epítopos contra influenza
CL2013002004A1 (es) Metodo y dispositivo para manipular el comportamiento de la interfaz de usuario que comprende crear un punto de insercion sobre una pagina de documento visualizada, detectar una entrada de usuario y dependiendo del area predefinida de acceso, permitir al usuario interactuar con la pagina.
CL2011001254A1 (es) Combinacion farmaceutica que comprende un anticuerpo que reconoce especificamente a cd38 y al menos melfalan; y su uso para el tratamiento contra el cancer.
CR10307A (es) Anteojos con caracteristicas de union a una mascarilla
CR20140318A (es) Composiciones intranasales de dexmedetomidina y métodos de uso de ellas
CL2011000513A1 (es) Metodos para reducir o inhibir la angiogenesis en un sujeto que tiene una enfermedad o condicion ocular asociada con la angiogenesis que comprende la administracion de un antagonista de tetraspanina 12(tspan12) y/o un antagonista de norrina.
BRPI0907260A2 (pt) "métodos, dispositivos e composições que liberam óxido nítrico"
CL2015003517A1 (es) Procedimiento para proporcionar una característica de seguridad a un documento de seguridad, y documento de seguridad.
CR20110553A (es) Terapia complementaria contra el cáncer
BRPI0915160A2 (pt) macacão para sala limpa e análoga
CL2008002381A1 (es) Oligonucleotido inmunoestimulador; composicion farmaceutica que lo comprende; y su uso para tratar un trastorno o afeccion en un sujeto, incluyendo cancer.
GT200800172A (es) Vacuna de mycoplasma hyoneumoniae
BRPI0921359A2 (pt) Antígenos que induzem a resposta imunológica contra flavivírus e métodos de uso dos mesmos
BRPI0821240B8 (pt) formas mutantes de estreptolisina o
NI201500150A (es) TRATAMIENTO DE CÁNCER CON DIHIDROPIRAZINO-PIRAZINAS×Se proporcionan en la presente método
PE20151435A1 (es) Laquinimod para reducir el dano talamico en la esclerosis multiple
BR112012014669A2 (pt) componente para artigo de fumar, artigo de fumar e método
BRPI0913175A2 (pt) artigo antibalístico, e, uso do mesmo.
CL2015001564A1 (es) Composición que comprende una triazina y su uso en el tratamiento intramuscular de coccidiosis o enfermedad protozoaria relacionada, en un mamífero no humano.
CL2011002569A1 (es) Procedimiento de tratamiento o prevencion que comprende administrar un inhibidor de tirosina cinasa y un inhibidor de igf-1r.
CO6700840A2 (es) Teobromina en combinación con un expectorante o un mucolítico para su uso en terapia
BR112014009322A8 (pt) inibidor de catecol-o-metiltransferase (comt), combinação do mesmo com um agente terapêutico adicional e agente terapêutico
CR20140293A (es) Preparaciones que comprenden emodepsido amorfo
MX2009004866A (es) Vacuna para enfermedad de lyme canina.

Legal Events

Date Code Title Description
FC Application refused